Treatment of highly virulent mammarenavirus infections-status quo and future directions.

Ivette A Nuñez Anya Crane Ian Crozier Gabriella Worwa J Thomas Beatty

Published in: Expert opinion on drug discovery (2024)

. The most promising treatment under development is a monoclonal antibody cocktail that is protective against multiple lineages of the Lassa virus in nonhuman primate disease models.

Keyphrases

monoclonal antibody
replacement therapy